Be Ahead With Economy And Policy Updates
Bengaluru: Aster DM Healthcare, one of the largest integrated healthcare providers in India, has invested Rs. 96 crore towards the expansion of its
New Jersey: Glenmark Pharmaceuticals Limited (Glenmark) has received final approval from the United States Food & Drug Administration (U.S. FDA) for Progesterone Vaginal
Ahmedabad: Zydus Lifesciences Limited (“Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Dapagliflozin Tablets, 5 mg
New Delhi: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for
New Jersey: Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced that it will manage end-to-end commercialization and distribution for RYALTRIS® (Olopatadine Hydrochloride and Mometasone
Mumbai: Global pharmaceutical leader, Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval
Midland, Texas, USA: CrudeChem Technology announced the launch of an additional 15 acre operational facility in Midland, Texas, marking a significant milestone in
New Delhi: Torrent Pharmaceuticals today announced the launch of its Semaglutide brands – Sembolic and Semalix – in India, in both oral and
Mumbai: Glenmark Pharmaceuticals Ltd (Glenmark), a research-led, global pharmaceutical company, announced the launch of GLIPIQⓇ (semaglutide) in India for the management of Type
Ahmedabad: Zydus Lifesciences Limited (including its subsidiaries, hereafter referred to as “Zydus”), an innovation led global lifesciences company, has launched Semaglutide Injection under the
Newsletter
NEET UG 2006 Canceled Over Paper Leak, Govt Orders CBI Probe and Re-Exam
TCS and Rezolve AI Join Hands to Accelerate Global Agentic Commerce Growth
Pine Labs Enters Philippines Market With GCash for Business as Its First Payments Partner
L&T Semiconductor Technologies Reports Multiyear License Agreement With Synopsys Inc
MobiKwik Announces Financial Results for Q4 FY26, Reports INR 632 Mn YoY Improvement